Ansal Buildwell share price & results

Ansal Buildwell Ltd.· Realty· Consumer Discretionary

Results to
Jun 2026
Ownership as of
Jun 2026
Start an Inve Case

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue17.4 ₹ crore+77.6% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin23.4 %−3.9 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit5.1 ₹ crore+292.2% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity3.53 %−5.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin2.48 %+22.8 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)21.79 %−31.5 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Price

₹83.93 −5.58% · −₹4.96

Last close 13 Oct 2026 · NSE · INR

Performance −20.5% 1Y

₹80₹100₹120₹140Oct 25Nov 25Jan 26Feb 26Apr 26May 26Jul 26Aug 26Oct 26

1Y: ₹105.6 on 10 Oct 2025 → ₹83.93. High ₹139.25 (14 Nov 2025), low ₹71.31 (7 Aug 2026).

Previous close
₹88.89
Market cap
₹63 Cr
52-week range
₹71.31 – ₹139.25
One year
−18.16%
Price to earnings (TTM to Jun 2026)
13.80×
Return on equity (TTM to Jun 2026)
3.53%

Overview

Symbol
NSE:ANSALBU
Sector
Realty
Industry
Consumer Discretionary
Exchange
NSE
Currency
INR

Your own record

Start an Inve Case for Ansal Buildwell Ltd.

Free account: one company. Everything above stays public.

Write why you follow Ansal Buildwell Ltd. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.